Table 2 Example of representative recombinant proteins produced via in vitro cultures
Recombinant proteins | Host plant species | Promoter | Protein yieldsa | References |
---|---|---|---|---|
Plant suspension cells | ||||
Anti-HIV antibody 2G12 | N. tabacum cv BY-2 | CaMV35S | 12 mg L−1 | [52] |
Human antibody M12 | N. tabacum cv BY-2 | CaMV35S | 107 mg L−1 | [53] |
Anti-hepatitis B surface antigen (HBsAg) mAb | N. tabacum cv BY-2 | CaMV35S | 15 mg L−1 | [54] |
Human growth hormone (hGH) | N. tabacum cv BY-2 | CaMV35S | 35 mg L−1 | [49] |
O. sativa cv Donjin | RAmy3D | [55] | ||
Human interferon α2b (hIFNα2) | N. tabacum cv BY-2 | CaMV35S | 28 mg L−1 | [48] |
Human α-1-antitrypsin (rAAT) | O. sativa | RAmy3D | 247 mg L−1 | [33] |
D. carota | CaMV35S | www.protalix.com | ||
hGM-CSF | O. sativa | RAmy3D | 129 mg L−1 | [56] |
Glucocerebrosidase | D. carota | CaMV35S | N/A | [57] |
α-Galactosidase-A (PRX-102) | D. carota | CaMV35S | N/A | [58] |
www.protalix.com | ||||
Human interleukin-12 (IL-12) | O. sativa | RAmy3D | 31 mg L−1 | [59] |
Human serum albumin (hSA) | O. sativa | RAmy3D | 45 mg L−1 | [60] |
Enhanced GFP | N. tabacum cv BY-2 | CaMV35S | 125–131 mg L−1 | [61] |
Hairy roots | ||||
Human antibody M12 | N. tabacum | CaMV35S | 5.9 mg L−1 | [62] |
Human antibody H10 | N. tabacum | CaMV35S | 2–3 mg L−1 | [63] |
N. benthamiana (DeltaXTFT) | ||||
Hepatitis B surface antigen (HBsAg) | Solanum tuberosum (var. Kufri bahar ) | (Aocs) 3 AmasPmas a | 97.1 ng g−1FW | [64] |
14D9 murine IgG1 | N. tabacum | CaMV35S | 64 mg L−1 | [65] |
Human epidermal growth factor (hEGF) | N. tabacum | CaMV35S | 2 ug g−1FW | [66] |
Thaumatin | N. tabacum | CaMV35S | 2.6 mg L−1 | [67] |
GFP | Brassica rapa rapa (turnip) | CaMV35S | 120 mg L−1 | [68] |
Human tissue plasminogen activator (tPA) | Cucumis melo L cv Geumssaragi-euncheon or N. tabacum | CaMV35S | 798 ug g−1FW or 900 ng mg TSP | |
Moss | ||||
Vascular endothelial growth factor (VEGF) | Physcomitrella patens | CaMV35S | 656 μg g−1DW | |
Erythropoietin (EPO) | P. patens | PpUbq1 b | 250 μg g−1DW | |
Complement factor H | P. patens | Ppact5-P c | 23.2 μg g−1DW (secreted); 25.8 μg g−1DW (intracellular) | [75] |
Multi-epitope fusion protein (HIV vaccine) | P. patens | Pca200P d | 3.7 μg g−1FW | [76] |
α-Galactosidase, β-glucocerebrosidase, FGF7/KGF | P. patens | N/A | N/A | [77]; www.greenovation.com |